{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:46:56Z","timestamp":1792619216461,"version":"4.5.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s12016-019-08754-9","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T04:03:22Z","timestamp":1562040202000},"page":"82-91","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":99,"title":["Resolvins: Emerging Players in Autoimmune and Inflammatory Diseases"],"prefix":"10.1007","volume":"58","author":[{"given":"Fereshte","family":"Abdolmaleki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2532-367X","authenticated-orcid":false,"given":"Petri T.","family":"Kovanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajab","family":"Mardani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad","family":"Gheibi-hayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,2]]},"reference":[{"key":"8754_CR1","unstructured":"Kumar V, Abbas AK, Fausto N, Aster JC (2014) Robbins and Cotran pathologic basis of disease, professional edition e-book. elsevier health sciences"},{"issue":"9","key":"8754_CR2","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","volume":"105","author":"P Libby","year":"2002","unstructured":"Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105(9):1135\u20131143","journal-title":"Circulation"},{"issue":"7","key":"8754_CR3","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","volume":"6","author":"GK Hansson","year":"2006","unstructured":"Hansson GK, Libby P (2006) The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6(7):508\u2013519","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"8754_CR4","doi-asserted-by":"publisher","first-page":"5922","DOI":"10.1021\/cr100396c","volume":"111","author":"CN Serhan","year":"2011","unstructured":"Serhan CN, Petasis NA (2011) Resolvins and protectins in inflammation resolution. Chem Rev 111(10):5922\u20135943. \nhttps:\/\/doi.org\/10.1021\/cr100396c","journal-title":"Chem Rev"},{"key":"8754_CR5","unstructured":"Majno G, Joris I (2004) Cells, tissues, and disease: principles of general pathology. Oxford University Press"},{"issue":"2","key":"8754_CR6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1096\/fj.06-7227rev","volume":"21","author":"CN Serhan","year":"2007","unstructured":"Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O\u2019Neill LA, Perretti M, Rossi AG, Wallace JL (2007) Resolution of inflammation: state of the art, definitions and terms. FASEB J 21(2):325\u2013332","journal-title":"FASEB J"},{"issue":"4","key":"8754_CR7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00418-004-0695-8","volume":"122","author":"CN Serhan","year":"2004","unstructured":"Serhan CN (2004) A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution. Histochem Cell Biol 122(4):305\u2013321","journal-title":"Histochem Cell Biol"},{"key":"8754_CR8","unstructured":"Serhan CN, Ward PA, Gilroy DW (2010) Fundamentals of inflammation. Cambridge University Press"},{"issue":"4","key":"8754_CR9","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.coph.2006.02.006","volume":"6","author":"JM Schwab","year":"2006","unstructured":"Schwab JM, Serhan CN (2006) Lipoxins and new lipid mediators in the resolution of inflammation. Curr Opin Pharmacol 6(4):414\u2013420","journal-title":"Curr Opin Pharmacol"},{"key":"8754_CR10","doi-asserted-by":"crossref","unstructured":"Crean D, Godson C (2015) Specialised lipid mediators and their targets. In: Seminars in immunology, vol 3. Elsevier, pp 169\u2013176","DOI":"10.1016\/j.smim.2015.05.002"},{"issue":"4819","key":"8754_CR11","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1126\/science.2820055","volume":"237","author":"B Samuelsson","year":"1987","unstructured":"Samuelsson B, Dahlen S-E, Lindgren JA, Rouzer CA, Serhan CN (1987) Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237(4819):1171\u20131176","journal-title":"Science"},{"key":"8754_CR12","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3389\/fimmu.2018.00288","volume":"9","author":"AA Manfredi","year":"2018","unstructured":"Manfredi AA, Ramirez GA, Rovere-Querini P, Maugeri N (2018) The neutrophil\u2019s choice: phagocytose vs make neutrophil extracellular traps. Front Immunol 9:288","journal-title":"Front Immunol"},{"issue":"11","key":"8754_CR13","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/ni.2987","volume":"15","author":"N Branzk","year":"2014","unstructured":"Branzk N, Lubojemska A, Hardison SE, Wang Q, Gutierrez MG, Brown GD, Papayannopoulos V (2014) Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens. Nat Immunol 15(11):1017\u20131025","journal-title":"Nat Immunol"},{"issue":"3","key":"8754_CR14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.immuni.2017.02.013","volume":"46","author":"A Warnatsch","year":"2017","unstructured":"Warnatsch A, Tsourouktsoglou T-D, Branzk N, Wang Q, Reincke S, Herbst S, Gutierrez M, Papayannopoulos V (2017) Reactive oxygen species localization programs inflammation to clear microbes of different size. Immunity 46(3):421\u2013432","journal-title":"Immunity"},{"issue":"3","key":"8754_CR15","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.chom.2012.06.011","volume":"12","author":"B McDonald","year":"2012","unstructured":"McDonald B, Urrutia R, Yipp BG, Jenne CN, Kubes P (2012) Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis. Cell Host Microbe 12(3):324\u2013333","journal-title":"Cell Host Microbe"},{"key":"8754_CR16","unstructured":"Kim S-J, Jenne CN (2016) Role of platelets in neutrophil extracellular trap (NET) production and tissue injury. In: Seminars in immunology, vol 6. Elsevier, pp 546\u2013554"},{"issue":"353","key":"8754_CR17","doi-asserted-by":"crossref","first-page":"353ra111","DOI":"10.1126\/scitranslmed.aaf7483","volume":"8","author":"V Chiurchi\u00f9","year":"2016","unstructured":"Chiurchi\u00f9 V, Leuti A, Dalli J, Jacobsson A, Battistini L, Maccarrone M, Serhan CN (2016) Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses. Sci Transl Med 8(353):353ra111","journal-title":"Sci Transl Med"},{"issue":"7","key":"8754_CR18","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","volume":"2","author":"BD Levy","year":"2001","unstructured":"Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN (2001) Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2(7):612\u2013619","journal-title":"Nat Immunol"},{"issue":"5","key":"8754_CR19","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1084\/jem.20042031","volume":"201","author":"M Arita","year":"2005","unstructured":"Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, Yang R, Petasis NA, Serhan CN (2005) Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 201(5):713\u2013722. \nhttps:\/\/doi.org\/10.1084\/jem.20042031","journal-title":"J Exp Med"},{"issue":"7395","key":"8754_CR20","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature11042","volume":"484","author":"N Chiang","year":"2012","unstructured":"Chiang N, Fredman G, B\u00e4ckhed F, Oh SF, Vickery T, Schmidt BA, Serhan CN (2012) Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 484(7395):524\u2013528","journal-title":"Nature"},{"issue":"7","key":"8754_CR21","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.cell.2011.12.006","volume":"147","author":"CZ Han","year":"2011","unstructured":"Han CZ, Ravichandran KS (2011) Metabolic connections during apoptotic cell engulfment. Cell 147(7):1442\u20131445","journal-title":"Cell"},{"key":"8754_CR22","doi-asserted-by":"crossref","unstructured":"K\u00f6r\u00f6sk\u00e9nyi K, Dur\u00f3 E, Pallai A, Sarang Z, Kloor D, Ucker DS, Beceiro S, Castrillo A, Chawla A, Ledent CA (2011) Involvement of adenosine A2A receptors in engulfment-dependent apoptotic cell suppression of inflammation. J Immunol 1002284","DOI":"10.4049\/jimmunol.1002284"},{"issue":"4","key":"8754_CR23","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.coph.2013.05.012","volume":"13","author":"CN Serhan","year":"2013","unstructured":"Serhan CN, Chiang N (2013) Resolution phase lipid mediators of inflammation: agonists of resolution. Curr Opin Pharmacol 13(4):632\u2013640","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"8754_CR24","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.chembiol.2012.11.010","volume":"20","author":"J Dalli","year":"2013","unstructured":"Dalli J, Winkler JW, Colas RA, Arnardottir H, Cheng C-YC, Chiang N, Petasis NA, Serhan CN (2013) Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents. Chem Biol 20(2):188\u2013201","journal-title":"Chem Biol"},{"issue":"7146","key":"8754_CR25","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nature05877","volume":"447","author":"JM Schwab","year":"2007","unstructured":"Schwab JM, Chiang N, Arita M, Serhan CN (2007) Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447(7146):869\u2013874","journal-title":"Nature"},{"issue":"10","key":"8754_CR26","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCRESAHA.110.223883","volume":"107","author":"M Spite","year":"2010","unstructured":"Spite M, Serhan CN (2010) Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins. Circ Res 107(10):1170\u20131184","journal-title":"Circ Res"},{"issue":"6917","key":"8754_CR27","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nature01320","volume":"420","author":"C Nathan","year":"2002","unstructured":"Nathan C (2002) Points of control in inflammation. Nature 420(6917):846\u2013852","journal-title":"Nature"},{"key":"8754_CR28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41569-019-0169-2","volume":"16","author":"M Back","year":"2019","unstructured":"Back M, Yurdagul A Jr, Tabas I, Oorni K, Kovanen PT (2019) Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat Rev Cardiol 16:389\u2013406. \nhttps:\/\/doi.org\/10.1038\/s41569-019-0169-2","journal-title":"Nat Rev Cardiol"},{"key":"8754_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1146\/annurev.immunol.25.022106.141647","volume":"25","author":"CN Serhan","year":"2007","unstructured":"Serhan CN (2007) Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 25:101\u2013137. \nhttps:\/\/doi.org\/10.1146\/annurev.immunol.25.022106.141647","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"8754_CR30","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.bbalip.2010.08.002","volume":"1801","author":"G Bannenberg","year":"2010","unstructured":"Bannenberg G, Serhan CN (2010) Specialized pro-resolving lipid mediators in the inflammatory response: an update. Biochim Biophys Acta 1801(12):1260\u20131273. \nhttps:\/\/doi.org\/10.1016\/j.bbalip.2010.08.002","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"8754_CR31","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.2353\/ajpath.2010.100322","volume":"177","author":"CN Serhan","year":"2010","unstructured":"Serhan CN (2010) Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? Am J Pathol 177(4):1576\u20131591. \nhttps:\/\/doi.org\/10.2353\/ajpath.2010.100322","journal-title":"Am J Pathol"},{"issue":"13","key":"8754_CR32","doi-asserted-by":"publisher","first-page":"9323","DOI":"10.1074\/jbc.M609212200","volume":"282","author":"YP Sun","year":"2007","unstructured":"Sun YP, Oh SF, Uddin J, Yang R, Gotlinger K, Campbell E, Colgan SP, Petasis NA, Serhan CN (2007) Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J Biol Chem 282(13):9323\u20139334. \nhttps:\/\/doi.org\/10.1074\/jbc.M609212200","journal-title":"J Biol Chem"},{"issue":"7268","key":"8754_CR33","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/nature08541","volume":"461","author":"M Spite","year":"2009","unstructured":"Spite M, Norling LV, Summers L, Yang R, Cooper D, Petasis NA, Flower RJ, Perretti M, Serhan CN (2009) Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461(7268):1287\u20131291. \nhttps:\/\/doi.org\/10.1038\/nature08541","journal-title":"Nature"},{"issue":"21","key":"8754_CR34","doi-asserted-by":"publisher","first-page":"7671","DOI":"10.1073\/pnas.0409271102","volume":"102","author":"M Arita","year":"2005","unstructured":"Arita M, Yoshida M, Hong S, Tjonahen E, Glickman JN, Petasis NA, Blumberg RS, Serhan CN (2005) Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc Natl Acad Sci U S A 102(21):7671\u20137676. \nhttps:\/\/doi.org\/10.1073\/pnas.0409271102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"8754_CR35","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1084\/jem.192.8.1197","volume":"192","author":"CN Serhan","year":"2000","unstructured":"Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K (2000) Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 192(8):1197\u20131204","journal-title":"J Exp Med"},{"issue":"13","key":"8754_CR36","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.2146\/ajhp080411","volume":"66","author":"JW Fetterman Jr","year":"2009","unstructured":"Fetterman JW Jr, Zdanowicz MM (2009) Therapeutic potential of n-3 polyunsaturated fatty acids in disease. Am J Health Syst Pharm 66(13):1169\u20131179. \nhttps:\/\/doi.org\/10.2146\/ajhp080411","journal-title":"Am J Health Syst Pharm"},{"issue":"6","key":"8754_CR37","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/07315724.2002.10719248","volume":"21","author":"AP Simopoulos","year":"2002","unstructured":"Simopoulos AP (2002) Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 21(6):495\u2013505","journal-title":"J Am Coll Nutr"},{"issue":"18","key":"8754_CR38","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1001\/archinte.161.18.2185","volume":"161","author":"CR Harper","year":"2001","unstructured":"Harper CR, Jacobson TA (2001) The fats of life: the role of omega-3 fatty acids in the prevention of coronary heart disease. Arch Intern Med 161(18):2185\u20132192","journal-title":"Arch Intern Med"},{"issue":"2","key":"8754_CR39","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1128\/IAI.02444-14","volume":"83","author":"BS Herrera","year":"2015","unstructured":"Herrera BS, Hasturk H, Kantarci A, Freire MO, Nguyen O, Kansal S, Van Dyke TE (2015) Impact of resolvin E1 on murine neutrophil phagocytosis in type 2 diabetes. Infect Immun 83(2):792\u2013801","journal-title":"Infect Immun"},{"key":"8754_CR40","doi-asserted-by":"crossref","unstructured":"Herov\u00e1 M, Schmid M, Gemperle C, Hersberger M (2015) ChemR23, the receptor for chemerin and resolvin E1, is expressed and functional on M1 but not on M2 macrophages. J Immunol 1402166","DOI":"10.4049\/jimmunol.1402166"},{"issue":"2","key":"8754_CR41","doi-asserted-by":"crossref","first-page":"836","DOI":"10.4049\/jimmunol.0901809","volume":"184","author":"H Seki","year":"2010","unstructured":"Seki H, Fukunaga K, Arita M, Arai H, Nakanishi H, Taguchi R, Miyasho T, Takamiya R, Asano K, Ishizaka A (2010) The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury. J Immunol 184(2):836\u2013843","journal-title":"J Immunol"},{"key":"8754_CR42","doi-asserted-by":"crossref","unstructured":"El Kebir D, Gjorstrup P, Filep JG (2012) Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation. Proc Natl Acad Sci 201206641","DOI":"10.1073\/pnas.1206641109"},{"issue":"5","key":"8754_CR43","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.4049\/jimmunol.180.5.3512","volume":"180","author":"S Hong","year":"2008","unstructured":"Hong S, Porter TF, Lu Y, Oh SF, Pillai PS, Serhan CN (2008) Resolvin E1 metabolome in local inactivation during inflammation-resolution. J Immunol 180(5):3512\u20133519","journal-title":"J Immunol"},{"key":"8754_CR44","doi-asserted-by":"crossref","unstructured":"Titos E, Rius B, Gonz\u00e1lez-P\u00e9riz A, L\u00f3pez-Vicario C, Mor\u00e1n-Salvador E, Mart\u00ednez-Clemente M, Arroyo V, Cl\u00e0ria J (2011) Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. J Immunol 1100225","DOI":"10.4049\/jimmunol.1100225"},{"issue":"7503","key":"8754_CR45","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","volume":"510","author":"CN Serhan","year":"2014","unstructured":"Serhan CN (2014) Pro-resolving lipid mediators are leads for resolution physiology. Nature 510(7503):92\u2013101","journal-title":"Nature"},{"issue":"4","key":"8754_CR46","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1476-5381.2009.00290.x","volume":"158","author":"P Kohli","year":"2009","unstructured":"Kohli P, Levy BD (2009) Resolvins and protectins: mediating solutions to inflammation. Br J Pharmacol 158(4):960\u2013971","journal-title":"Br J Pharmacol"},{"issue":"2","key":"8754_CR47","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/CMR.00046-08","volume":"22","author":"TH Mogensen","year":"2009","unstructured":"Mogensen TH (2009) Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 22(2):240\u2013273","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"8754_CR48","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1096\/fj.14-265363","volume":"29","author":"D Akagi","year":"2015","unstructured":"Akagi D, Chen M, Toy R, Chatterjee A, Conte MS (2015) Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice. FASEB J 29(6):2504\u20132513","journal-title":"FASEB J"},{"issue":"4","key":"8754_CR49","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1073\/pnas.0907342107","volume":"107","author":"S Krishnamoorthy","year":"2010","unstructured":"Krishnamoorthy S, Recchiuti A, Chiang N, Yacoubian S, Lee C-H, Yang R, Petasis NA, Serhan CN (2010) Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci 107(4):1660\u20131665","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"8754_CR50","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.ajpath.2012.01.028","volume":"180","author":"S Krishnamoorthy","year":"2012","unstructured":"Krishnamoorthy S, Recchiuti A, Chiang N, Fredman G, Serhan CN (2012) Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. Am J Pathol 180(5):2018\u20132027","journal-title":"Am J Pathol"},{"issue":"50","key":"8754_CR51","doi-asserted-by":"crossref","first-page":"18433","DOI":"10.1523\/JNEUROSCI.4192-11.2011","volume":"31","author":"C-K Park","year":"2011","unstructured":"Park C-K, Xu Z-Z, Liu T, L\u00fc N, Serhan CN, Ji R-R (2011) Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1\/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1. J Neurosci 31(50):18433\u201318438","journal-title":"J Neurosci"},{"issue":"4","key":"8754_CR52","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pupt.2011.04.001","volume":"24","author":"B Wang","year":"2011","unstructured":"Wang B, Gong X, J-y W, Zhang L, Zhang Z, Li H-z, Min S (2011) Resolvin D1 protects mice from LPS-induced acute lung injury. Pulm Pharmacol Ther 24(4):434\u2013441","journal-title":"Pulm Pharmacol Ther"},{"issue":"1","key":"8754_CR53","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1465-9921-13-110","volume":"13","author":"Z Liao","year":"2012","unstructured":"Liao Z, Dong J, Wu W, Yang T, Wang T, Guo L, Chen L, Xu D, Wen F (2012) Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPAR\u03b3\/NF-\u03baB pathway. Respir Res 13(1):110","journal-title":"Respir Res"},{"issue":"4","key":"8754_CR54","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/joim.12395","volume":"278","author":"L Wang","year":"2015","unstructured":"Wang L, Wang FS, Gershwin ME (2015) Human autoimmune diseases: a comprehensive update. J Intern Med 278(4):369\u2013395","journal-title":"J Intern Med"},{"issue":"5","key":"8754_CR55","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nm1590","volume":"13","author":"R Baccala","year":"2007","unstructured":"Baccala R, Hoebe K, Kono DH, Beutler B, Theofilopoulos AN (2007) TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat Med 13(5):543\u2013551","journal-title":"Nat Med"},{"issue":"10","key":"8754_CR56","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1097\/01.ASN.0000032417.73640.72","volume":"13","author":"S Mitchell","year":"2002","unstructured":"Mitchell S, Thomas G, Harvey K, Cottell D, Reville K, Berlasconi G, Petasis NA, Erwig L, Rees AJ, Savill J (2002) Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. J Am Soc Nephrol 13(10):2497\u20132507","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"8754_CR57","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.cellsig.2006.03.011","volume":"18","author":"G Milligan","year":"2006","unstructured":"Milligan G, Stoddart LA, Brown AJ (2006) G protein-coupled receptors for free fatty acids. Cell Signal 18(9):1360\u20131365. \nhttps:\/\/doi.org\/10.1016\/j.cellsig.2006.03.011","journal-title":"Cell Signal"},{"issue":"4","key":"8754_CR58","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2009.21","volume":"5","author":"DL Eizirik","year":"2009","unstructured":"Eizirik DL, Colli ML, Ortis F (2009) The role of inflammation in insulitis and \u03b2-cell loss in type 1 diabetes. Nat Rev Endocrinol 5(4):219\u2013226","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"8754_CR59","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20020760","volume":"196","author":"CN Serhan","year":"2002","unstructured":"Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac R-L (2002) Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 196(8):1025\u20131037","journal-title":"J Exp Med"},{"issue":"3\u20134","key":"8754_CR60","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.plefa.2005.05.003","volume":"73","author":"N Chiang","year":"2005","unstructured":"Chiang N, Arita M, Serhan CN (2005) Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. Prostaglandins Leukot Essent Fat Acids 73(3\u20134):163\u2013177","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"issue":"5","key":"8754_CR61","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","volume":"142","author":"DY Oh","year":"2010","unstructured":"Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, Li P, Lu WJ, Watkins SM, Olefsky JM (2010) GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142(5):687\u2013698","journal-title":"Cell"},{"key":"8754_CR62","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1476-511x-10-76","volume":"10","author":"UN Das","year":"2011","unstructured":"Das UN (2011) Lipoxins as biomarkers of lupus and other inflammatory conditions. Lipids Health Dis 10:76. \nhttps:\/\/doi.org\/10.1186\/1476-511x-10-76","journal-title":"Lipids Health Dis"},{"key":"8754_CR63","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1745-7580-4-5","volume":"4","author":"JE Lattin","year":"2008","unstructured":"Lattin JE, Schroder K, Su AI, Walker JR, Zhang J, Wiltshire T, Saijo K, Glass CK, Hume DA, Kellie S, Sweet MJ (2008) Expression analysis of G protein-coupled receptors in mouse macrophages. Immunome Res 4:5. \nhttps:\/\/doi.org\/10.1186\/1745-7580-4-5","journal-title":"Immunome Res"},{"issue":"6","key":"8754_CR64","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/ibd.20109","volume":"13","author":"KH Weylandt","year":"2007","unstructured":"Weylandt KH, Kang JX, Wiedenmann B, Baumgart DC (2007) Lipoxins and resolvins in inflammatory bowel disease. Inflamm Bowel Dis 13(6):797\u2013799. \nhttps:\/\/doi.org\/10.1002\/ibd.20109","journal-title":"Inflamm Bowel Dis"},{"key":"8754_CR65","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.0105-2896.2005.00292.x","volume":"206","author":"BL Kelsall","year":"2005","unstructured":"Kelsall BL, Leon F (2005) Involvement of intestinal dendritic cells in oral tolerance, immunity to pathogens, and inflammatory bowel disease. Immunol Rev 206:132\u2013148. \nhttps:\/\/doi.org\/10.1111\/j.0105-2896.2005.00292.x","journal-title":"Immunol Rev"},{"issue":"2","key":"8754_CR66","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1136\/gut.2004.040360","volume":"54","author":"DC Baumgart","year":"2005","unstructured":"Baumgart DC, Metzke D, Schmitz J, Scheffold A, Sturm A, Wiedenmann B, Dignass AU (2005) Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells. Gut 54(2):228\u2013236. \nhttps:\/\/doi.org\/10.1136\/gut.2004.040360","journal-title":"Gut"},{"key":"8754_CR67","doi-asserted-by":"crossref","unstructured":"Allen B (1991) Fish oil in combination with other therapies in the treatment of psoriasis. In: Health effects of omega 3 polyunsaturated fatty acids in seafoods, vol 66. Karger Publishers, pp 436\u2013445","DOI":"10.1159\/000419312"},{"issue":"5","key":"8754_CR68","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/rheumatology\/36.5.513","volume":"36","author":"L Cleland","year":"1997","unstructured":"Cleland L, James M (1997) Rheumatoid arthritis and the balance of dietary N-6 and N-3 essential fatty acids. Br J Rheumatol 36(5):513\u2013514","journal-title":"Br J Rheumatol"},{"issue":"1 Suppl","key":"8754_CR69","doi-asserted-by":"publisher","first-page":"349s","DOI":"10.1093\/ajcn\/71.1.349s","volume":"71","author":"JM Kremer","year":"2000","unstructured":"Kremer JM (2000) N-3 fatty acid supplements in rheumatoid arthritis. Am J Clin Nutr 71(1 Suppl):349s\u2013351s. \nhttps:\/\/doi.org\/10.1093\/ajcn\/71.1.349s","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"8754_CR70","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","volume":"380","author":"DL Bhatt","year":"2019","unstructured":"Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C (2019) Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med 380(1):11\u201322","journal-title":"N Engl J Med"},{"issue":"9497","key":"8754_CR71","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/s0140-6736(05)67665-9","volume":"366","author":"RA Hughes","year":"2005","unstructured":"Hughes RA, Cornblath DR (2005) Guillain-Barre syndrome. Lancet (London, England) 366(9497):1653\u20131666. \nhttps:\/\/doi.org\/10.1016\/s0140-6736(05)67665-9","journal-title":"Lancet (London, England)"},{"key":"8754_CR72","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1529-8027.2012.00392.x","volume":"17","author":"B Soliven","year":"2012","unstructured":"Soliven B (2012) Autoimmune neuropathies: insights from animal models. J Peripher Nerv Syst 17:28\u201333","journal-title":"J Peripher Nerv Syst"},{"issue":"6","key":"8754_CR73","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1586\/17476348.2.6.753","volume":"2","author":"JH Yun","year":"2008","unstructured":"Yun JH, Henson PM, Tuder RM (2008) Phagocytic clearance of apoptotic cells: role in lung disease. Exp Rev Respir Med 2(6):753\u2013765. \nhttps:\/\/doi.org\/10.1586\/17476348.2.6.753","journal-title":"Exp Rev Respir Med"},{"issue":"11","key":"8754_CR74","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/intimm\/dxn106","volume":"20","author":"F Annunziato","year":"2008","unstructured":"Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S (2008) The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation. Int Immunol 20(11):1361\u20131368. \nhttps:\/\/doi.org\/10.1093\/intimm\/dxn106","journal-title":"Int Immunol"},{"issue":"4","key":"8754_CR75","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1172\/JCI1112","volume":"101","author":"VA Fadok","year":"1998","unstructured":"Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine\/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 101(4):890\u2013898","journal-title":"J Clin Invest"},{"issue":"29","key":"8754_CR76","doi-asserted-by":"publisher","first-page":"12099","DOI":"10.1073\/pnas.0705268104","volume":"104","author":"A Kimura","year":"2007","unstructured":"Kimura A, Naka T, Kishimoto T (2007) IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells. Proc Natl Acad Sci 104(29):12099\u201312104. \nhttps:\/\/doi.org\/10.1073\/pnas.0705268104","journal-title":"Proc Natl Acad Sci"},{"key":"8754_CR77","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12974-014-0225-0","volume":"12","author":"B Luchting","year":"2015","unstructured":"Luchting B, Rachinger-Adam B, Heyn J, Hinske LC, Kreth S, Azad SC (2015) Anti-inflammatory T-cell shift in neuropathic pain. J Neuroinflammation 12:12. \nhttps:\/\/doi.org\/10.1186\/s12974-014-0225-0","journal-title":"J Neuroinflammation"},{"issue":"5","key":"8754_CR78","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.4049\/jimmunol.0901088","volume":"183","author":"Z Zhang","year":"2009","unstructured":"Zhang Z, Zhang ZY, Schluesener HJ (2009) Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects. J Immunol 183(5):3081\u20133091. \nhttps:\/\/doi.org\/10.4049\/jimmunol.0901088","journal-title":"J Immunol"},{"issue":"37","key":"8754_CR79","doi-asserted-by":"publisher","first-page":"9590","DOI":"10.1523\/jneurosci.0020-16.2016","volume":"36","author":"B Luo","year":"2016","unstructured":"Luo B, Han F, Xu K, Wang J, Liu Z, Shen Z, Li J, Liu Y, Jiang M, Zhang ZY, Zhang Z (2016) Resolvin D1 programs inflammation resolution by increasing TGF-beta expression induced by dying cell clearance in experimental autoimmune neuritis. J Neurosci 36(37):9590\u20139603. \nhttps:\/\/doi.org\/10.1523\/jneurosci.0020-16.2016","journal-title":"J Neurosci"},{"issue":"4","key":"8754_CR80","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1124\/mol.114.094649","volume":"86","author":"A Dhopeshwarkar","year":"2014","unstructured":"Dhopeshwarkar A, Mackie K (2014) CB2 cannabinoid receptors as a therapeutic target\u2014what does the future hold? Mol Pharmacol 86(4):430\u2013437","journal-title":"Mol Pharmacol"},{"issue":"3","key":"8754_CR81","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11481-013-9445-9","volume":"8","author":"S Rom","year":"2013","unstructured":"Rom S, Persidsky Y (2013) Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation. J NeuroImmune Pharmacol 8(3):608\u2013620","journal-title":"J NeuroImmune Pharmacol"},{"issue":"23","key":"8754_CR82","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1007\/s00018-016-2300-4","volume":"73","author":"C Turcotte","year":"2016","unstructured":"Turcotte C, Blanchet M-R, Laviolette M, Flamand N (2016) The CB 2 receptor and its role as a regulator of inflammation. Cell Mol Life Sci 73(23):4449\u20134470","journal-title":"Cell Mol Life Sci"},{"issue":"13","key":"8754_CR83","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/j.bmc.2014.04.062","volume":"22","author":"MA Tepper","year":"2014","unstructured":"Tepper MA, Zurier RB, Burstein SH (2014) Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity. Bioorg Med Chem 22(13):3245\u20133251","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"8754_CR84","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/cpt.980","volume":"104","author":"MP Motwani","year":"2018","unstructured":"Motwani MP, Bennett F, Norris PC, Maini AA, George MJ, Newson J, Henderson A, Hobbs AJ, Tepper M, White B (2018) Potent anti-inflammatory and pro-resolving effects of anabasum in a human model of self-resolving acute inflammation. Clin Pharmacol Ther 104(4):675\u2013686","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"8754_CR85","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/1529-0131(199801)41:1<163::AID-ART20>3.0.CO;2-9","volume":"41","author":"RB Zurier","year":"1998","unstructured":"Zurier RB, Rossetti RG, Lane JH, Goldberg JM, Hunter SA, Burstein SH (1998) Dimethylheptyl-THC-11 OIC acid: a nonpsychoactive antiinflammatory agent with a cannabinoid template structure. Arthritis Rheum 41(1):163\u2013170","journal-title":"Arthritis Rheum"},{"issue":"5","key":"8754_CR86","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1096\/fj.08-118323","volume":"23","author":"RB Zurier","year":"2009","unstructured":"Zurier RB, Sun Y-P, George KL, Stebulis JA, Rossetti RG, Skulas A, Judge E, Serhan CN (2009) Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4. FASEB J 23(5):1503\u20131509","journal-title":"FASEB J"},{"issue":"9","key":"8754_CR87","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/annrheumdis-2011-200314","volume":"71","author":"EG Gonzalez","year":"2012","unstructured":"Gonzalez EG, Selvi E, Balistreri E, Akhmetshina A, Palumbo K, Lorenzini S, Lazzerini PE, Montilli C, Capecchi PL, Lucattelli M (2012) Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis. Ann Rheum Dis 71(9):1545\u20131551","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8754_CR88","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12931-016-0373-0","volume":"17","author":"M Lucattelli","year":"2016","unstructured":"Lucattelli M, Fineschi S, Selvi E, Gonzalez EG, Bartalesi B, De Cunto G, Lorenzini S, Galeazzi M, Lungarella G (2016) Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung. Respir Res 17(1):49","journal-title":"Respir Res"},{"key":"8754_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01645","volume":"9","author":"F Abdolmaleki","year":"2018","unstructured":"Abdolmaleki F, Farahani N, Gheibi Hayat SM, Pirro M, Bianconi V, Barreto GE, Sahebkar A (2018) The role of efferocytosis in autoimmune diseases. Front Immunol 9:1645. \nhttps:\/\/doi.org\/10.3389\/fimmu.2018.01645","journal-title":"Front Immunol"},{"issue":"2","key":"8754_CR90","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/imcb.12206","volume":"97","author":"SM Gheibi Hayat","year":"2019","unstructured":"Gheibi Hayat SM, Bianconi V, Pirro M, Sahebkar A (2019) Efferocytosis: molecular mechanisms and pathophysiological perspectives. Immunol Cell Biol 97(2):124\u2013133. \nhttps:\/\/doi.org\/10.1111\/imcb.12206","journal-title":"Immunol Cell Biol"},{"key":"8754_CR91","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.arr.2019.01.007","volume":"50","author":"A Tajbakhsh","year":"2019","unstructured":"Tajbakhsh A, Gheibi Hayat SM, Butler AE, Sahebkar A (2019) Effect of soluble cleavage products of important receptors\/ligands on efferocytosis: their role in inflammatory, autoimmune and cardiovascular disease. Ageing Res Rev 50:43\u201357. \nhttps:\/\/doi.org\/10.1016\/j.arr.2019.01.007","journal-title":"Ageing Res Rev"},{"key":"8754_CR92","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.pharmthera.2018.02.003","volume":"188","author":"A Tajbakhsh","year":"2018","unstructured":"Tajbakhsh A, Rezaee M, Kovanen PT, Sahebkar A (2018) Efferocytosis in atherosclerotic lesions: malfunctioning regulatory pathways and control mechanisms. Pharmacol Ther 188:12\u201325. \nhttps:\/\/doi.org\/10.1016\/j.pharmthera.2018.02.003","journal-title":"Pharmacol Ther"},{"issue":"3","key":"8754_CR93","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1097-2765(04)00237-0","volume":"14","author":"K Lauber","year":"2004","unstructured":"Lauber K, Blumenthal SG, Waibel M, Wesselborg S (2004) Clearance of apoptotic cells: getting rid of the corpses. Mol Cell 14(3):277\u2013287","journal-title":"Mol Cell"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-019-08754-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-019-08754-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-019-08754-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T20:16:44Z","timestamp":1593548204000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-019-08754-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,2]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["8754"],"URL":"https:\/\/doi.org\/10.1007\/s12016-019-08754-9","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,2]]},"assertion":[{"value":"2 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"No informed consent was required to prepare the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}